Company / Operating Income
Sana Biotechnology, Inc. Operating Income History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Income
-$272.7M
FY2024
5-year range
-$356.9M / -$272.6M
FY2020-FY2024
Trend
+7.0%
vs FY2023
Sector context
#160 of 204
Health Care
What the data says
Sana Biotechnology, Inc.'s operating income of -$273M is lower than 78% of companies in the Health Care sector (FY2024). Operating Income has fluctuated over the past 6 years, ranging from -$357M in FY2021 to -$141M in FY2019.
Based on SEC 10-K filings.
-$273M in FY2024.
Remained stable around -$273M over the past 2 years.
Health Care sector context is included.
Operating Income over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 22% in Health CareTop 78% of 204This company -$272.7M Sector average $107.7M
▼
-353.2% below sector average
Key checks
Key Insights
- In FY2024, operating income increased 7.0% year-over-year.
- Ranks #160 out of 204 companies in the Health Care sector.
- Peak operating income was recorded in FY2019.
- Lowest operating income in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.11 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating IncomeValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | -$272.7M | +7.0% |
| FY2023 | -$293.1M | -7.5% |
| FY2022 | -$272.6M | +23.6% |
| FY2021 | -$356.9M | -24.7% |
| FY2020 | -$286.1M | -102.7% |
| FY2019 | -$141.2M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026